Common heart drug might dampen some autism symptoms
December 11, 2012 by Serena Gordon, Healthday Reporter in Autism spectrum disorders
Study found benefit most pronounced in those with milder forms of developmental disorder.
(HealthDay)—A medication typically prescribed to control high blood pressure that's commonly referred to as a water pill may ease some of the symptoms of autism, researchers say.
That's especially true for people who have milder forms of the disorder, the new research indicates.
"Bumetanide is a promising novel therapeutic agent to treat autism," wrote the study's authors, who were quick to point out that this treatment is not a cure for autism and that larger trials need to be done to determine who would benefit most from this treatment.
Results of the study appear online Dec. 11 in the journal Translational Psychiatry.
Autism is a developmental disorder that results in communication problems, social difficulties, repetitive behaviors and restricted interests, according to background information in the study. The exact cause of the disorder isn't yet known, though genetic and environmental factors are believed to play a role.
Scientists have also studied neurotransmitters, suspecting that these chemical messengers in the brain might not be working as they should in people with autism. Gamma-aminobutyric acid (GABA) is one such neurotransmitter, and the medication bumetanide appears to be able to alter the function of GABA, at least in animals, according to the researchers.
In this latest study, the researchers gave 60 children who had been diagnosed with autism or Asperger's syndrome either 1 milligram of bumetanide or an inactive placebo pill daily. All of the children were between 3 and 11, and the study period lasted three months.
The severity of autism was determined by videotaped evaluations done on the first day of the study and the 90th day, by researchers who didn't know which children had received active treatment and which had been given a placebo pill.
Using several standardized autism assessment tools, the researchers found that bumetanide improved autism symptoms. The effects of the medication were more pronounced in children with milder autism. In case reports included in the study, some of the improvements seen included more eye contact, improved non-verbal communication and better social communication.
Side effects were very mild, though the use of the drug does require periodic monitoring for potassium levels; one child in the study had low potassium levels.
Senior study author Yehezkel Ben-Ari, founder of the Institute of Neurobiology of the Mediterranean Sea in Bohars, France, said the authors believe that the improvement in symptoms is due to an effect on GABA caused by the drug.
One expert said the findings look promising.
"This is a very interesting study. The authors have taken a medication that's been on the back shelf for decades and, surprisingly, found a clinically significant benefit when used in children with autism, especially those on the milder end of the spectrum," noted Dr. Andrew Adesman, chief of developmental and behavioral pediatrics at the Steven and Alexandra Cohen Children's Medical Center of New York in New Hyde Park, N.Y.
"Children would need to be on this medication indefinitely, because their improvements deteriorate when the medication is stopped. And, we don't yet know if there are any long-term concerns," he said. "Hopefully, this study will be a catalyst to new research. We need to see additional studies before we can recommend this treatment widely, but since it's already FDA-approved, we should know more in just a few years."
More information: To learn more about autism, visit the U.S. Department of Health and Human Services.
Journal reference:
Translational Psychiatry
Copyright © 2012 HealthDay. All rights reserved.
-
New clinical trial to examine medication to treat social withdrawal in Fragile X and autism
Jul 20, 2011 |
not rated yet |
0
-
Children with autism frequently receive psychotropic medications
May 02, 2010 |
not rated yet |
0
-
Research lacking on drugs for older children with autism, study finds
Sep 24, 2012 |
not rated yet |
0
-
Study explores link between smoking during pregnancy, autism
Apr 26, 2012 |
not rated yet |
0
-
Study shows delays in siblings of children with autism spectrum disorders
May 16, 2012 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Image of a Convex Lens Cut in Half Horizontally
1 hour ago
-
Ray tracing throught optical system of thick lenses
1 hour ago
-
Faraday's law on circular wire
2 hours ago
-
Specific Exergy vs Specific Flow Exergy
3 hours ago
-
The Durability of Bone: Long Falls
11 hours ago
-
Is energy convertible to matter?
13 hours ago
- More from Physics Forums - Classical Physics
More news stories
Enrichment therapy effective among children with autism, study finds
Children with autism showed significant improvement after six months of simple sensory exercises at home using everyday items such as scents, spoons and sponges, according to UC Irvine neurobiologists.
Autism spectrum disorders
20 hours ago |
3 / 5 (1) |
0
|
Researcher helps give children with autism the chance to communicate
Research by Victoria University PhD education graduand Larah van der Meer highlights the importance of understanding the communication preferences of children with developmental disabilities such as autism.
Autism spectrum disorders
May 14, 2013 |
3.3 / 5 (3) |
1
Developers dive in to create a wealth of autism apps
At times, Andy Shih still finds himself overwhelmed by the groundswell of interest in autism applications he's seen in the three years since Apple Inc. released the first iPad.
Autism spectrum disorders
May 09, 2013 |
2 / 5 (1) |
0
Enhanced motion perception in autism may point to an underlying cause of the disorder
Children with autism see simple movement twice as quickly as other children their age, and this hypersensitivity to motion may provide clues to a fundamental cause of the developmental disorder, according ...
Autism spectrum disorders
May 08, 2013 |
not rated yet |
0
|
Autism scientists seek more brains to aid research
(AP)—Autism scientists are seeking more brain samples for research.
Autism spectrum disorders
May 02, 2013 |
5 / 5 (1) |
0
Addiction to unhealthy foods could help explain the global obesity epidemic
Research presented today shows that high-fructose corn syrup can cause behavioural reactions in rats similar to those produced by drugs of abuse such as cocaine. These results, presented by addiction expert Francesco Leri, ...
Facing the chill wind of blood pressure
(Medical Xpress)—High blood pressure is something that has traditionally been a problem in Scotland, but might there be a link to our climate?
US health care: Does more spending yield better health?
(Medical Xpress)—Health care spending is much higher for older Americans than for younger adults and children, on average, and analysts have said that increasing spending leads to longer life expectancy.
Study shows low rate of late lumen loss with bioresorbable DESolve device
The DESolve bioresorbable coronary scaffold system achieves good efficacy and safety with low rates of late lumen loss and major coronary adverse events at six months, show first results from the pivotal DESolve Nx trial ...
Study finds COPD is over-diagnosed among uninsured patients
More than 40 percent of patients being treated for COPD at a federally funded clinic did not have the disease, researchers found after evaluating the patients with spirometry, the diagnostic "gold standard" for chronic obstructive ...
Registry questions superiority of bivalirudin over heparin
Results from a large observational study reported at EuroPCR 2013 today question whether bivalirudin is superior to heparin in the absence of GPIIb/IIIa blockade, showing similar 30-day mortality in patients with non-ST segment ...